Dermata Therapeutics, Inc. financial statements
Dermata Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 7.56M | 10-K |
| Cash and equivalents | USD 7.52M | 10-Q |
Dermata Therapeutics, Inc. financials on 6ix · Dermata Therapeutics, Inc. on 6ix